E-DRUG Archives (by thread)

  • [e-drug] Maintaining the integrity of the clinical evidence base, e-drug
  • [e-drug] Pharmacoeconomics - Evidence, Money & Selection, David Newby
  • [e-drug] Maintaining the integrity of the clinical evidence base (2), Tom Poe
  • [e-drug] RFI-Essential drug lists revised in 2000 & 2001, Richard Laing
  • [e-drug] Debate on Drug Advertising in Europe, Lisa Hayes
  • [e-drug] azithromycin sources, Beverley Snell
  • [e-drug] dipyrone, Reuven Miller
  • [e-drug] WHO to take over the fight against aids, Gaelle Krikorian
  • [e-drug] Azithromycin sources (2), Vanda Zidoniene
  • [e-drug] Crisis in Argentina, Carlota Merchán
  • [e-drug] Azithromycin sources (3), Vladimir S. Shoukhov
  • [e-drug] Azithromycin sources (4), Dr.L.Offerhaus
  • [e-drug] Azithromycin sources (5), Carmen PEREZ
  • [e-drug] Pressure on profits drug companies, E-drug
  • [e-drug] Patent on HIV2 Preventing Licence of Rapid Testing (2), Gonsalves , Gregg
  • [e-drug] Patent on HIV2 Preventing Licence of Rapid Testing, Gonsalves , Gregg
  • [e-drug] Azithromycin sources (6), Warren Kaplan
  • [e-drug] RFI-Essential drug lists revised in 2000 & 2001 (2), Ayesha Ahmed
  • [e-drug] Dipyrone (2), Ayesha Ahmed
  • [e-drug] Felicity Mayfield - Tribute, Bada Pharasi
  • [e-drug] Azithromycin sources (7), Joel Lexchin
  • [e-drug] Ouagadougou Appeal, Olivier Jablonski
  • [e-drug] Reusing bottles in the drug manufacturing, e-drug
  • [e-drug] DTCA debate heats up in Brussels, Lisa Hayes
  • [e-drug] Reusing bottles in the drug manufacturing (2), Wong Wai See
  • [e-drug] ARV coordinator needed for Botswana, e-drug
  • [e-drug] Resuing bottles in drug manufacturing (3), Michael Anisfeld
  • [e-drug] Position Available at USP, Nancy Blum
  • [e-drug] Information on pill usage, Pat Menick
  • [e-drug] Press Conference at la revue Prescrire Paris, January 24, Christophe Kopp
  • [e-drug] Drug Registration in Tonga, Jean Spinks
  • [e-drug] Availability and price of rofecoxib, Ayesha Ahmed
  • [e-drug] Availability and price of rofecoxib (2), Eggert Sigfusson
  • [e-drug] Availability and price of rofecoxib (3), David Henry
  • [e-drug] Information on pill usage (2), Scott.Hillstrom
  • [e-drug] Impact of drug policy on anti-microbial resistance, Kathy Holloway
  • [e-drug] Availability and price of rofecoxib (4), Annalisa Campomori
  • [e-drug] essential drug mission Afghanistan, hartlg
  • [e-drug] Impact of drug policy on anti-microbial resistance (2), <m.t.ham@minvws.nl>
  • [e-drug] Availability and price of rofecoxib (5), Vanda Zidoniene
  • [e-drug] Impact of drug policy on anti-microbial resistance (4), Warren Kaplan
  • [e-drug] Impact of drug policy on anti-microbial resistance (3), Ken Harvey
  • [e-drug] Information on pill usage (3), Sharon Mitchell
  • [e-drug] Availability and price of rofecoxib (6), Joel Lexchin
  • [e-drug] Availability and price of rofecoxib (7), Lynn Weekes
  • [e-drug] Availability and price of rofecoxib (8), Daniel Domosbian
  • [e-drug] women, drugs and trade agreeements, Elvire Beleoken
  • [e-drug] Public heath groups statement to WHO - EB, Lisa Hayes
  • [e-drug] Drug Interactions, Lars Bjerrum
  • [e-drug] Australian PBS recommends listing Sildenafil citrate, Ken Harvey
  • [e-drug] Banning metamisole in Moldova, DrugInfo Moldova
  • [e-drug] Azithromycin sources (8), DrugInfo Moldova
  • [e-drug] Availability and price of rofecoxib (9), <office@drugs.mldnet.com>
  • [e-drug] Banning metamisole in Moldova (2), Dr.L.Offerhaus
  • [e-drug] Banning metamisole in Moldova (4), Vladimir S. Shoukhov
  • [e-drug] Banning metamisole in Moldova (5), Vladimir S. Shoukhov
  • [e-drug] Banning metamisole in Moldova (3), Vladimir S. Shoukhov
  • [e-drug] Banning metamisole in Moldova (6), Sukkari , Sana
  • [e-drug] Banning metamisole in Moldova (7), Beverley Snell
  • [e-drug] Pharm Ind in Sweden lobbies against PI, Staffan Svensson
  • [e-drug] Banning metamisole in Moldova (8), Jorg Schaaber
  • [e-drug] ARV Monitoring tools on the web, Gregg , Gonsalves
  • [e-drug] Delivery of INRUD News, Chalker , John
  • [e-drug] Banning metamisole in Moldova (9), Sukkari , Sana
  • [e-drug] Church based drug supply systems, Richard Laing
  • [e-drug] Paroxetine withdrawal symptoms and dependence, Charles Medawar
  • [e-drug] Expensive vaccines not needed?, andy
  • [e-drug] HAI statement at WHO Exec Board on Access to Ess Drugs, hai
  • [e-drug] Use of antimicrobials in fish, animals and plants and, e-drug
  • [e-drug] Pharm Ind in Sweden lobbies against PI (2), J.W.F. van Mil
  • [e-drug] Request for Sources, Mohamed Gad
  • [e-drug] URL for Mission drug supply report, Richard Laing
  • [e-drug] Request for Sources (2), Andy Gray
  • [e-drug] Drug Information Database or system, Marita van Rooyen
  • [e-drug] Codeine in cough mixtures, Beverley Snell
  • [e-drug] Codeine in cough mixtures (cont), rtrinkle
  • [e-drug] Expensive vaccines not needed? (cont), Wittet, Scott
  • [e-drug] Nevirapine donation, BUKO Pharma-Kampagne
  • [e-drug] Identification of counterfeit drugs, Schleiden-Schmid
  • [e-drug] Banning of Metamizole in Maldova (cont), pharmid
  • [e-drug] Identification of counterfeit drugs (cont), Ham, dhr. dr. M. ten
  • [e-drug] Nevirapine donation (cont), Cecile MACE
  • [e-drug] Important Press Alert (28 Jan, 2002), 28 Jan, 2002
  • [e-drug] NGO letter to WTO regarding medical technology exports and, James Love
  • [e-drug] Drug Formulary, Michelle Ooi
  • [e-drug] TAC and MSF import generic ARVs into South Africa, e-drug
  • [e-drug] Drug Price Increase in Pakistan, Azhar Hussain
  • [e-drug] Drug Formulary (cont), Annalisa Campomori
  • [e-drug] International price information services, everardm
  • [e-drug] PM backs veto on subsidising Viagra on Australian PBS, Ken Harvey
  • [e-drug] HIV/AIDS drug price, lkasonde
  • [e-drug] ARVs - Asian countries' essential drugs lists?, Manel Kappagoda
  • [e-drug] HIV/AIDS drug price (cont), Joel Lexchin
    • Mail converted by MHonArc 2.6.8